Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

NCT00483652 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Fampridine-SR
DRUG: Placebo

Sponsor

Acorda Therapeutics